Company Filing History:
Years Active: 2002-2003
Title: The Innovative Contributions of David Limburg
Introduction
David Limburg is an accomplished inventor based in Baltimore, MD, known for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Limburg has focused on developing novel compounds that have the potential to impact medical research and therapeutic applications.
Latest Patents
Limburg's latest patents include "Trisubstituted carbocyclic cyclophilin binding compounds and their use." This invention relates to novel, non-peptidic small organic compounds that exhibit an affinity for cyclophilin-type immunophilin proteins. The patent outlines pharmaceutical compositions that incorporate these compounds, emphasizing their potential uses in binding CyP-type proteins and inhibiting their peptidyl-prolyl isomerase activity. This innovation holds promise for various medical disorders. Another notable patent is for "Cyclic ester or amide derivatives," which describes low molecular weight cyclic esters and amides that also target FKBP-type immunophilins. These compounds are designed to affect neuronal activity, showcasing Limburg's commitment to advancing medical science.
Career Highlights
Throughout his career, David Limburg has worked with notable companies such as Guilford Pharmaceuticals, Inc. and Gpi Nil Holdings Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Limburg has collaborated with esteemed colleagues, including Gregory S. Hamilton and Yong-Qian Wu. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patented technologies.
Conclusion
David Limburg's work exemplifies the spirit of innovation in the pharmaceutical field. His patents reflect a dedication to improving medical treatments and advancing scientific knowledge. Through his contributions, Limburg continues to make a significant impact on the industry.